Biomarkers for Risk Stratification in Lung Cancer
Nodule Solitary Pulmonary, Non-small Cell Lung Cancer, Lung cancer screening, Biomarkers of lung cancer, Circulating tumor DNA, Low dose computed tomography of lung, Pulmonary nodule, Lung Neoplasms, Guardant Health ct-DNA LUNAR assay, Benign nodule on screening CT, Incidental benign nodule, Suspicious nodule, Suspicious incidental nodule
Lead Scientist at UCSF
- Mehrdad Arjomandi, M.D.
Dr. Arjomandi grew up in Ahvaz, a small city in Southwestern Iran, and moved to the United States in 1986 in the aftermath of Iranian revolution (1979), Iraq's invasion of Iran (1980-88), and his family displacement inside Iran (1980-83).
- accepting new patients
- Start Date
- Completion Date
- University of California, San Francisco
- Study Type
- Observational [Patient Registry]
- Expecting 590 study participants
- Last Updated